Skip to main content

A PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING DOSES OF A VACCINE-BASED IMMUNOTHERAPY REGIMEN (VBIR) FOR PROSTATE CANCER (PF-06753512)

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Pfizer, Inc.

Start Date

July 1, 2016

End Date

December 31, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Pfizer, Inc.

Start Date

July 1, 2016

End Date

December 31, 2021